Natural Killer Activity in Spleens and Lymph Nodes from Patients with Hodgkin's Disease¹

Natural killer (NK) activity against K-562 myeloid cell line was evaluated in 21 spleens and 14 lymph nodes from patients with Hodgkin's disease (HD). NK activity of eight HD-involved (HD⁺) spleens [556 lytic units (LU)] was found 5-fold higher than that of 13 HD-uninvolved (HD^-) spleens (112 LU) (p < 0.01). Moreover, NK activity of HD⁺ spleens was significantly different (p < 0.05) from that of three spleens involved by non-HD lymphoma (100 LU). NK activity of four spleens from nonneoplastic patients (250 LU) was intermediate between those of HD⁺ and HD^- spleens. Lymph node cells were about 10-fold less cytotoxic. NK activity of seven HD⁺ lymph nodes (43 LU) was 3-fold higher than that of three lymph nodes involved by non-HD lymphoma (8 LU). However, these differences were not statistically significant. Our data are compatible with increased NK activity in HD⁺ tissues as well as with depressed NK activity in HD^- tissues. The observation that NK activity of peripheral blood leukocytes from nine HD patients (116 LU) (p < 0.05 only at 100:1 effector:target cell ratio) may support the latter interpretation. Partial characterization of effector cells in HD⁺ and in HD^- spleens indicated that, in both instances, NK cells were nonadherent and almost equally distributed between the erythrocyte-negative and -positive cell fractions. Finally, NK activity of both HD⁺ and HD^- spleen cells could be further potentiated in vitro by interferon.